Is EBITDA Flawed And Misleading For U.S. Cannabis Companies?

Is EBITDA Flawed And Misleading For U.S. Cannabis Companies?

Is EBITDA flawed and misleading for US cannabis companies?
Cannabis investments has garnered a lot of attention; initially, for valuations and share prices raising sky high, and later, for those share prices coming down to earth. As this industry moves from …
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *